Your browser doesn't support javascript.
loading
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia.
Mims, A; Walker, A R; Huang, X; Sun, J; Wang, H; Santhanam, R; Dorrance, A M; Walker, C; Hoellerbauer, P; Tarighat, S S; Chan, K K; Klisovic, R B; Perrotti, D; Caligiuri, M A; Byrd, J C; Chen, C-S; James Lee, L; Jacob, S; Mrózek, K; Bloomfield, C D; Blum, W; Garzon, R; Schwind, S; Marcucci, G.
Affiliation
  • Mims A; Department of Internal Medicine, The Ohio State University and The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Leukemia ; 27(4): 871-8, 2013 Apr.
Article in En | MEDLINE | ID: mdl-23178755

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylbutyrates / Azacitidine / Leukemia, Myeloid, Acute / MicroRNAs / Epigenesis, Genetic / Histone Deacetylase Inhibitors Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylbutyrates / Azacitidine / Leukemia, Myeloid, Acute / MicroRNAs / Epigenesis, Genetic / Histone Deacetylase Inhibitors Limits: Animals / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom